Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease

Journal of Experimental Medicine

Volumn 184, Issue 6, 1996, Pages 2371-2384

  Evans, Claire F ^a   Horwitz, Marc S ^a   Hobbs, Monte V ^a   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ANTIGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS GLYCOPROTEIN; VIRUS NUCLEOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC INFLAMMATION; CONTROLLED STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY CELL; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS INFECTION;

ANIMALS; AUTOIMMUNE DISEASES; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC MEMORY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGODENDROGLIA; POLYMERASE CHAIN REACTION; SPINAL CORD; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 0030443139     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.6.2371     Document Type: Article

References (57)

1. Jahnke, U., E.H. Fischer, and E.C.J. Alvord. 1985. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science (Wash. DC). 229: 282-284.
2. Fujinami, R.S., and M.B.A. Oldstone. 1985. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: a mechanism for autoimmunity. Science (Wash. DC). 230:1043-1045.
3. Fujinami, R.S. 1988. Virus-induced autoimmunity through molecular mimicry. Ann. NY Acad. Sci. 540:210-217.
4. Oldstone, M.B.A. 1987. Molecular mimicry and autoimmune disease. Cell. 50:819-820.
5. Hall, R. 1994. Molecular mimicry. Adv. Parasitol. 34:81-132.
6. Atkinson, M.A., M.A. Bowman, L. Campbell, B.L. Darrow, D.L. Kaufman, and N.K. Maclaren. 1994. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin dependent diabetes. J. Clin. Invest. 94:2125-2129.
7. Fielder, M., S.J. Pirt, I. Tarpey, C. Wilson, P. Cunningham, C. Ettelaie, S. Binder, and A. Ebringer. 1995. Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella. FEBS Lett. 369:243-248.
8. Oomes, P.G., B.C. Jacobs, M.P. Hazenberg, J.R. Banffer, and F.G. van der Meche. 1995. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barre syndrome: evidence of molecular mimicry. Ann. Neurol. 38:170-175.
9. Shimoda, S., M. Nakamura, H. Ishibashi, K. Hayashida, and Y. Niho. 1995. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J. Exp. Med. 181:1835-1845.
10. Wucherpfennig, K.W., and J.L. Stominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:695-705.
11. Talbot, J.P., J.S. Paquette, C. Ciurli, J.P. Antel, and F. Quellet. 1996. Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann. Neurol. 39: 233-240.
12. Banki, K., E. Colombo, F. Sia, D. Halladay, D.H. Mattson, A.H. Tatum, P.T. Massa, P.E. Phillips, and A. Perl. 1994. Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J. Exp. Med. 180:1649-1663.
13. Whitton, J.L., and M.B.A. Oldstone. 1988. The recognition of virus-infected cells by cytotoxic T lymphocytes. Int. Pediat. 3:16-21.
14. Buchmeier, M.J., R.M. Welsh, F.J. Dutko, and M.B.A. Oldstone. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30: 275-331.
15. b major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J. Virol. 69:2297-2305.
16. Whitton, L.L., A. Tishon, H. Lewicki, J. Gebhard, T. Cook, M. Salvato, E. Joly, and M.B.A. Oldstone. 1989. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J. Virol. 63:4303-4310.
17. Evans, C.F., P. Borrow, J.C. de la Torre, and M.B.A. Oldstone. 1994. Virus-induced immunosuppression: kinetic analysis of the selection of a mutation associated with viral persistence. J. Virol. 68:7367-7373.
18. Gow, A., V.L. Friedrich, and R.A. Lazzarini. 1992. Myelin basic protein gene contains separate enhancers for oligodendrocyte and Schwann cell expression. J. Cell Biol. 119:605-616.
19. Oldstone, M.B.A., M. Nerenberg, P. Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell. 65:319-331.
20. + T cells from young and old mice. J. Immunol. 150:3602-3614.
21. - cells and cell subsets from young and old mice. Cell. Immunol. 154:264-272.
22. Dudov, K.P., and R.P. Perry. 1984. The gene family encoding the mouse ribosomal protein L32 contains a uniquely expressed intron-containing gene and an unmutated processed gene. Cell. 37:457-468.
23. Dutko, F.J., and M.B.A. Oldstone. 1983. Genomic and biological variation among commonly-used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1689-1698.
24. Buchmeier, M.J., and W. Rawls. 1977. Variation between strains of hamsters in the lethality of Pichinde virus infections. Infect. Immun. 16:1413-1421.
25. Whitton, J.L., P.J. Southern, and M.B.A. Oldstone. 1988. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology. 162:321-327.
26. Jones, B.J., and D.J. Roberts. 1968. The quantitative measurement of motor incoordination in naive mice using an accelerating rotarod. J. Pharm. Pharmac. 20:302-304.
27. Laffan, E.W., C.A. Lisciotto, D.A. Gapp, and D.A. Weldon. 1989. Development of rotorod performance in normal and congenitally hypothyroid mutant mice. Behav. Neural Biol. 52:411-416.
28. Demotz, S., H.M. Grey, and A. Sette. 1990. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science (Wash. DC). 249:1028-1030.
29. Whitton, J.L., and M.B.A. Oldstone. 1989. Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes. J. Exp. Med. 170:1033-1038.
30. Byrne, J.A., and M.B.A. Oldstone. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. II. Clearance of virus in vivo. J. Virol. 51: 682-686.
31. Cole, G.A., N. Nathanson, and R.A. Pendergast. 1972. Requirements for θ-bearing cells: lymphocytic choriomeningitis virus induced central nervous system disease. Nature (Lond.). 238:335-337.
32. Hickey, W.F., B.L. Hsu, and H. Kimura. 1991. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28:254-260.
33. Selin, L.K., S.R. Nahill, and R.M. Welsh. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 179:1933-1943.
34. Talbot, P.J., J.-S. Paquette, F. Quellet, and J.P. Antel. 1995. T cells cross-reactive to myelin basic protein and human respiratory coronavirus 229E in multiple sclerosis patients. Neurol. 45(Suppl.):A383-1384.
35. Pette, M., K. Fujita, B. Kitze, J.N. Whitaker, E. Albert, L. Kappos, and H. Wekerle. 1990. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology. 40:1770-1776.
36. Massa, P.T., K. Ozato, and D.E. McFarlin. 1993. Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia. 8:201-207.
37. Wong, G.H.W., I. Clark-Lewis, A.W. Harris, and J.W. Schrader. 1984. Effect of cloned interferon-γ on expression of H-2 and Ia antigens on cell lines of hematopoietic, lymphoid, epithelial, fibroblastic and neuronal origin. Eur. J. Immunol. 14:52-56.
38. Wong, G.H.W., P.F. Bartlett, I. Clark-Lewis, F. Battye, and J.W. Schrader. 1984. Inducible expression of H-2 and Ia antigens on brain cells. Nature (Lond.). 310:688-691.
39. Lavi, E., A. Suzumura, D.M. Murasko, E.M. Murray, D.H. Silberberg, and S.R. Weiss. 1988. Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocyces. Annu. NY Acad. Sci. 540:488-490.
40. Selmaj, K.W., and C.S. Raine. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339-346.
41. Selmaj, K., C.S. Raine, M. Farooq, W.T. Norton, and C.F. Brosnan. 1991. Cytokine cytotoxicity against oligodendrocytes. J. Immunol. 147:1522-1529.
42. Julien, J., and X. Ferrer. 1989. Multiple sclerosis: an overview. Biomed. Pharmacother. 43:335-346.
43. Allen, I., and B. Brankin. 1993. Pathogenesis of multiple sclerosis - the immune diathesis and the role of viruses. J. Neuropathol. Exp. Neurol. 52:95-105.
44. Guerder, S., F. Meyerhoff, and R. Flavell. 1994. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity. 1:155-166.
45. Fallis, R.J., C.S. Raine, and D.E. McFarlin. 1989. Chronic relapsing experimental allergic encephalomyelitis in SJL mice following the adoptive transfer of an epitope-specific T cell line. J. Neuroimmunol. 22:93-105.
46. Mokhtarian, F., D.E. McFarlin, and C.S. Raine. 1984. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature (Lond.). 309:356-358.
47. Ohashi, P.S., S. Oehen, K. Buerki, H. Pircher, C.T. Ohashi, B. Odermatt, B. Malissen, R.M. Zinkernagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:305-317.
48. Goverman, J., A. Woods, L. Larson, L.P. Weiner, L. Hood, and D.M. Zaller. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 72:551-560.
49. + T cells in respiratory virus infections. J. Immunol. 154:6013-6021.
50. De Clercq, E. 1987. Interferon induction by polynucleotides, modified polynucleotides and polycarboxylates. Methods Enzymol. 78:227-236.
51. Field, A.K., A.A. Tytell, G.P. Lampson, and M.R. Hilleman. 1967. Inducers of interferon and host resistance, II. Multistranded synthetic polynucleotide complexes. Biochemistry 58: 1004-1010.
52. Nahill, S.R., and R.M. Welsh. 1993. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J. Exp. Med. 177:317-327.
53. Hafler, D., D.A. Fos, D. Benjamin, M.L. Blue, and H.L. Weiner. 1987. Secondary immune amplification following live poliovirus immunization in humans. Clin. Immunol. Immunopathol. 44:321-328.
54. Andersen, O., P.E. Lygner, T. Bergstrom, M. Andersson, and A. Vahlne. 1993. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J. Neurol. 240:417-422.
55. Panitch, H.S., C.T.J. Bever, E. Katz, and K.P. Johnson. 1991. Upper respiratory tract infections trigger attacks of multiple sclerosis in patients treated with interferon. J. Neuroimmunol. 35(Suppl. 1):125.
56. Sibley, W.A. 1985. Clinical viral infections and multiple sclerosis. Lancet. 1985:1313-1315.
57. Kurtzke, J.F. 1980. Epidemiologic contributions to multiple sclerosis: an overview. Neurology. 30:61-79.